HIGH PH REDUCES DNA-DAMAGE CAUSED BY BILE FROM PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS - ANTACIDS MAY ATTENUATE DUODENAL POLYPOSIS

被引:22
作者
SCATES, DK
VENITT, S
PHILLIPS, RKS
SPIGELMAN, AD
机构
[1] ST MARYS HOSP,SCH MED,ACAD SURG UNIT,POLYPOSIS REGISTRY,LONDON W2 1NY,ENGLAND
[2] ROYAL CANC HOSP,INST CANC RES,HADDOW LABS,MOLEC CARCINOGENESIS SECT,SUTTON,SURREY,ENGLAND
[3] UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,ACAD SURG UNIT,LONDON W2 1PG,ENGLAND
关键词
FAMILIAL ADENOMATOUS POLYPOSIS; ANTACIDS; DUODENAL PH; DNA ADDUCTS;
D O I
10.1136/gut.36.6.918
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Patients with familial adenomatous polyposis (FAP) develop periampullary duodenal tumours, suggesting that bile contributes to their formation. The hypothesis that bile contains carcinogens has been tested by looking for DNA adducts (markers of carcinogen exposure) in the duodenum of patients with or without FAP and by determining whether bile can produce DNA adducts in vitro. Using P-32-postlabelling to detect adducts, there was an excess (compared with unaffected patients) of DNA adducts in the duodenum of FAP patients and an excess of DNA adducts in the small bowel of rats treated with FAP bile, while bile from FAP patients formed significantly more DNA adducts in vitro than did bile from controls. In this study it is shown that the excess of adduct labelling produced by FAP bile in vitro depends on the pH of the incubate. While adduct labelling at pH 6-8 did not differ significantly between bile from six FAP patients and six controls, at pH 4-5 FAP bile, but not control bile, produced a near threefold excess of adduct labelling over that at pH 6-8. Therapy that increases duodenal pH may therefore alleviate duodenal polyposis.
引用
收藏
页码:918 / 921
页数:4
相关论文
共 14 条
[1]  
Spigelman A.D., Williams C.B., Talbot I.C., Domizio P., Phillips R.K.S., Upper gastrointestinal cancer in patients with familial adenomatous polyposis, Lancet, 2, pp. 783-785, (1989)
[2]  
Spigelman A.D., Talbot I.C., Penna C., Nugent K.P., Phillips R.K.S., Costello C., Et al., The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis (FAP), J Clin Pathol, 47, pp. 709-710, (1994)
[3]  
Offerhaus G.J.A., Giardiello F.M., Krush A.J., Booker S.V., Tersmette A.C., Kelley N.C., Hamilton S.T., The risk of upper gastrointestinal cancer in familial adenomatous polyposis, Gastroenterology, 106, pp. 1980-1982, (1992)
[4]  
Penna C., Phillips R.K.S., Tiret E., Spigelman A.D., Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: Experience of two European centres, Br J Surg, 80, pp. 1027-1029, (1993)
[5]  
Venitt S., Biological mechanisms, Hunter's Diseases of Occupations. 8th Ed., pp. 623-653, (1994)
[6]  
Watson W.P., Post-labelling for detecting DNA damage, Mutagenesis, 2, pp. 319-331, (1987)
[7]  
Spigelman A.D., Scates D.K., Venitt S., Phillips R.K.S., DNA adducts, detected by <sup>32</sup>P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls, Carcinogenesis, 12, pp. 1727-1732, (1991)
[8]  
Scates D.K., Spigelman A.D., Phillips R.K.S., Venitt S., DNA adducts, detected by <sup>32</sup>P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls, Carcinogenesis, 13, pp. 731-735, (1992)
[9]  
Scates D.K., Spigelman A.D., Nugent K.P., Phillips R.K.S., Venitt S., DNA adducts, detected by <sup>32</sup>P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls, Carcinogenesis, 14, pp. 1107-1110, (1993)
[10]  
Gupta R.C., Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo, Proc Natl Acad Sci USA, 81, pp. 6943-6947, (1984)